BRIEF published on 11/13/2024 at 10:30, 8 days 3 hours ago Eresos Holdings PLC to Trade Shares on JP Jenkins JP Jenkins CBD Products Unlisted Trading Eresos Holdings Matched Bargain
PRESS RELEASE published on 11/13/2024 at 10:25, 8 days 3 hours ago Eresos Holdings PLC Shares soon to be trading on JP Jenkins Eresos Holdings PLC to trade on JP Jenkins platform offering CBD-infused products. Shares to go live on 2nd Dec 2024 in London, UK JP Jenkins London Share Trading Eresos Holdings PLC CBD-infused Products
BRIEF published on 11/01/2024 at 10:29, 20 days 3 hours ago Sondrel Holdings Announces CEO Transition for Future Growth Growth Strategy CEO Transition Technology Company Leadership Change Sondrel Holdings
PRESS RELEASE published on 11/01/2024 at 10:24, 20 days 3 hours ago Sondrel Holdings Ltd Announces CEO transition to Lead Next Phase of Growth Sondrel Holdings Ltd announces CEO transition as Oliver Jones succeeds John Chubb to lead the next phase of growth. Read more about the leadership change and its impact CEO Transition Growth Phase Sondrel Holdings Ltd Oliver Jones John Chubb
BRIEF published on 11/01/2024 at 08:05, 20 days 5 hours ago Sondrel Holdings Appoints Mark Julio as New CFO Financial Expertise New CFO Sondrel Holdings Mark Julio Chip Design
PRESS RELEASE published on 11/01/2024 at 08:00, 20 days 5 hours ago Sondrel Holdings Ltd (SND.JPJ) Announces Appointment of Mark Julio as New CFO Sondrel Holdings Ltd announces Mark Julio as new CFO, bringing valuable finance experience to lead the company's future growth in ultra-complex custom chips for tech brands CFO Finance Experience Mark Julio Sondrel Holdings Ltd Custom Chips
BRIEF published on 10/23/2024 at 14:32, 28 days 23 hours ago Cambria Africa Plc Shares Begin Trading on JP Jenkins JP Jenkins Share Trading Cambria Africa Zimbabwe Investments Asset Divestment
PRESS RELEASE published on 10/23/2024 at 14:27, 28 days 23 hours ago CAMBRIA AFRICA PLC Shares now trading on JP Jenkins CAMBRIA AFRICA PLC shares now available for trading on JP Jenkins platform. Company focused on divesting assets and maximizing shareholder value Shareholder Value JP Jenkins Shares Trading CAMBRIA AFRICA PLC Divesting Assets
BRIEF published on 09/05/2024 at 08:35, 2 months 16 days ago 350 PPM Limited Shares Now Trading on JP Jenkins Growth JP Jenkins Trade 350 PPM Environmental Business
PRESS RELEASE published on 09/05/2024 at 08:30, 2 months 16 days ago 350 PPM Limited shares now trading on JP Jenkins 350 PPM Limited's shares now available for trading on JP Jenkins, a platform for unlisted assets. The UK-based company focuses on environmental businesses and carbon reduction Shares Carbon Reduction JP Jenkins Environmental Business 350 PPM Limited
Published on 11/21/2024 at 13:30, 10 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:00, 40 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 40 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 40 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 40 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 5 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 25 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 42 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 20 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 55 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 55 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
